← FDA Drug Approvals (Drugs@FDA)

PBZ

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1948-02-19

Drug application

FDA Application #

NDA005914

Application type

New Drug Application

Brand name

PBZ

Generic name

Tripelennamine Citrate

Active ingredients

TRIPELENNAMINE CITRATE

Dosage form

ELIXIR

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1948-02-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown